Back
Prelude Therapeutics, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
PRLD
Prelude Therapeutics, Inc.
Last Price:
$1.45
Seasonality Move:
-0.12%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.
Prelude Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.53 | Sell |
| 20-day SMA: | 1.51 | Sell |
| 50-day SMA: | 1.53 | Sell |
| 200-day SMA: | 1.05 | Buy |
| 8-day EMA: | 1.5 | Sell |
| 20-day EMA: | 1.54 | Sell |
| 50-day EMA: | 1.48 | Sell |
| 200-day EMA: | 1.37 | Buy |
Prelude Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.23 | Sell |
| Chaikin Money Flow: | -140968 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 2.12) | Sell |
| Bollinger Bands (100): | (0.88 - 1.66) | Buy |
Prelude Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Prelude Therapeutics, Inc. Stock
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 1.46 while PRLD 8-day simple moving average is 1.53, which is a Sell signal.
-
The stock price of PRLD is 1.46 while Prelude Therapeutics, Inc. 20-day SMA is 1.51, which makes it a Sell.
-
Prelude Therapeutics, Inc. 50-day simple moving average is 1.53 while PRLD share price is 1.46, making it a Sell technically.
-
PRLD stock price is 1.46 and Prelude Therapeutics, Inc. 200-day simple moving average is 1.05, creating a Buy signal.
PRLD Technical Analysis vs Fundamental Analysis
Sell
37
Prelude Therapeutics, Inc. (PRLD)
is a Sell
Is Prelude Therapeutics, Inc. a Buy or a Sell?
-
Prelude Therapeutics, Inc. stock is rated a SellThe current Prelude Therapeutics, Inc. [PRLD] share price is $1.46. The Score for PRLD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Prelude Therapeutics, Inc. Stock Info
Market Cap:
91.8M
Price in USD:
1.46
Share Volume:
292.8K
Prelude Therapeutics, Inc. 52-Week Range
52-Week High:
4.22
52-Week Low:
0.61
Sell
37
Prelude Therapeutics, Inc. (PRLD)
is a Sell
Prelude Therapeutics, Inc. Share Price Forecast
-
What is the Prelude Therapeutics, Inc. stock price today?The Prelude Therapeutics, Inc. stock price is 1.46 USD today.
-
Will PRLD stock go up or go down?Prelude Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Prelude Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Prelude Therapeutics, Inc. is overvalued.
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 1.46 while PRLD 8-day exponential moving average is 1.50, which is a Sell signal.
-
The stock price of PRLD is 1.46 while Prelude Therapeutics, Inc. 20-day EMA is 1.54, which makes it a Sell.
-
Prelude Therapeutics, Inc. 50-day exponential moving average is 1.48 while PRLD share price is 1.46, making it a Sell technically.
-
PRLD stock price is 1.46 and Prelude Therapeutics, Inc. 200-day simple moving average is 1.37, creating a Buy signal.
Fundamental Analysis of Prelude Therapeutics, Inc.
Is Prelude Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.13 per share.
Technical Analysis of Prelude Therapeutics, Inc.
Should I short Prelude Therapeutics, Inc. stock?
-
PRLD Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Prelude Therapeutics, Inc. is a Sell
-
Prelude Therapeutics, Inc. Relative Strength Index (RSI) is 48.23, which suggest Prelude Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Prelude Therapeutics, Inc. is (1.1 - 2.12), which suggest Prelude Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Prelude Therapeutics, Inc. is (0.88 - 1.66), which suggest Prelude Therapeutics, Inc. is a Buy
* Prelude Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.